Parkside Financial Bank & Trust’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $897 | Buy |
+71
| New | +$897 | ﹤0.01% | 2303 |
|
|
2023
Q3 | – | Sell |
-140
| Closed | -$3K | – | 2063 |
|
|
2023
Q2 | $3K | Buy |
140
+96
| +218% | +$2.05K | ﹤0.01% | 1555 |
|
|
2023
Q1 | $1.78K | Hold |
44
| – | – | ﹤0.01% | 1734 |
|
|
2022
Q4 | $2.05K | Sell |
44
-15
| -25% | -$698 | ﹤0.01% | 1675 |
|
|
2022
Q3 | $3K | Buy |
59
+57
| +2,850% | +$2.9K | ﹤0.01% | 1393 |
|
|
2022
Q2 | $0 | Sell |
2
-59
| -97% | – | ﹤0.01% | 1846 |
|
|
2022
Q1 | $4K | Sell |
61
-5
| -8% | -$328 | ﹤0.01% | 1366 |
|
|
2021
Q4 | $5K | Hold |
66
| – | – | ﹤0.01% | 1300 |
|
|
2021
Q3 | $4K | Sell |
66
-2
| -3% | -$121 | ﹤0.01% | 1316 |
|
|
2021
Q2 | $3K | Buy |
68
+6
| +10% | +$265 | ﹤0.01% | 1410 |
|
|
2021
Q1 | $3K | Buy |
62
+35
| +130% | +$1.69K | ﹤0.01% | 1369 |
|
|
2020
Q4 | $1K | Sell |
27
-15
| -36% | -$556 | ﹤0.01% | 1511 |
|
|
2020
Q3 | $2K | Hold |
42
| – | – | ﹤0.01% | 1151 |
|
|
2020
Q2 | $2K | Hold |
42
| – | – | ﹤0.01% | 1150 |
|
|
2020
Q1 | $2K | Buy |
42
+23
| +121% | +$1.1K | ﹤0.01% | 1096 |
|
|
2019
Q4 | $1K | Sell |
19
-7
| -27% | -$368 | ﹤0.01% | 1366 |
|
|
2019
Q3 | $2K | Hold |
26
| – | – | ﹤0.01% | 1143 |
|
|
2019
Q2 | $2K | Hold |
26
| – | – | ﹤0.01% | 1161 |
|
|
2019
Q1 | $2K | Buy |
26
+13
| +100% | +$1K | ﹤0.01% | 1151 |
|
|
2018
Q4 | $1K | Hold |
13
| – | – | ﹤0.01% | 1199 |
|
|
2018
Q3 | $1K | Hold |
13
| – | – | ﹤0.01% | 1247 |
|
|
2018
Q2 | $2K | Hold |
13
| – | – | ﹤0.01% | 1047 |
|
|
2018
Q1 | $1K | Hold |
13
| – | – | ﹤0.01% | 1166 |
|
|
2017
Q4 | $1K | Hold |
13
| – | – | ﹤0.01% | 1114 |
|
|
2017
Q3 | $1K | Hold |
13
| – | – | ﹤0.01% | 1112 |
|
|
2017
Q2 | $0 | Hold |
13
| – | – | ﹤0.01% | 1440 |
|
|
2017
Q1 | $0 | Buy |
+13
| New | – | ﹤0.01% | 1395 |
|